Headache and Migraine

Researchers examined two possible risk factors for migraine that potentially can be modified – having obesity and being underweight.

Research includes impact of body weight on migraine risk, effect of sleep on MS relapse, and side effects of statins in stroke survivors.

From the first hand-held vagus nerve stimulator for episodic cluster headache to a TMS therapy system for depression, we highlight 5 new technologies.

Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.

April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.

Is there a common biological pathway underlying ischemic stroke and migraine in young patients?

Studies have shown that true acupuncture is more effective than sham acupuncture in reducing migraine, but it treatment feasible?

March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.

A review examined risk of medication overuse headache across classes of acute migraine treatments.

SPG is known to be an effective treatment among adults with migraine, but little is known about its use in the pediatric population.

Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.

Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.

February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.

Researchers tested the efficacy of neuromodulation of the sphenopalatine ganglion to treat patients with drug-refractory cluster headaches.

Cognitive behavioral therapy to treat migraine in children and adolescents proved beneficial, but were the results long-lasting?

Studies that have evaluated the association between migraine and CV outcomes have shown inconsistent results.

Three new studies explore preventing secondary stroke, a potential biomarker for MS prediction, and a link between vitamin D and headache.

A trial of chiropractic spinal manipulative therapy (CSMT) to treat migraine successfully blinded its patients to the trial intervention.

Perioperative stroke is associated with a significantly increased risk for mortality and long-term morbidities. What role does migraine history play?

January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.

From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.

Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.

November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.

Research has linked rosacea with other neurologic conditions such as Parkinson disease and MS, but an association with migraine has been unclear.

There is no FDA-approved drug for pediatric migraine in children aged younger than 12, so treatment is consensus-based rather than evidence-based.